Choose a country to view content specific to your location
Choose a country to view content specific to your location
CA242 is related to the sialylated Lewis (a) blood group antigen (CA19-9) and is found on the same mucin complex as CA50 and sialylated Lewis A (CA19-9), but it is chemically and immunologically distinct. CA242 and CA19-9 are co-expressed on different epitopes but on the same carbohydrate macromolecule and similar to CA19-9, CA242 is used as a tumor marker for the early diagnosis of pancreatic cancer. Compared to CA19-9, CA242 has high specificity but lower sensitivity in diagnosing pancreatic cancer and so it is generally used in combination with CA50 or CEA to optimize the assay performance.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |
